bone mass endometriosi patient gnrh agonist implant danazol treatment trabecular bone miner content lumbar spine femor neck differ endometriosi patient age-match control subject monthli goserelin implant serum estradiol level menopaus rang mean decreas pre-treat valu lumbar spine femor neck month month treatment valu differ control group valu littl period signific increas baselin valu urinari calcium-creatinin ratio serum alkalin phosphatas danazol-tr subject level earli follicular-phas rang signific chang bone assess normal mens month cessat medic six month goserelin treatment lumbar spine femor neck bone miner content valu differ pre-treat control valu urinari calcium-creatinin ratio wherea serum alkalin phosphatas rapid deep suppress ovarian steroidogenesi monthli goserelin implant signific bone loss control danazol group loss month cessat treatment bone densiti time differ control studi number patient period question complet revers 